Articles dans des revues avec comité de lecture (260)
  1. 83. Saussez, S., de Leval, L., Decaestecker, C., Sirtaine, N., Cludts, S., Duray, A., Chevalier, D., André, S., Gabius, H.-J., Remmelink, M., & Leroy, X. (2010). Galectin fingerprinting in Warthin's tumors: lectin-based approach to trace its origin? Histology and histopathology, 25(5), 541-550.
  2. 84. Pozdzik, A., Berton, A., Schmeiser, H. H., Missoum, W., Decaestecker, C., Salmon, I., Vanherweghem, J.-L., & Nortier, J. (2010). Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity? Histopathology, 56(4), 449-463. doi:10.1111/j.1365-2559.2010.03509.x
  3. 85. Wauthoz, N., Deleuze, P., Hecq, J., Roland, I., Saussez, S., Adanja, I., Debeir, O., Decaestecker, C., Mathieu, V., Kiss, R., & Amighi, K. (2010). In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy. European journal of pharmaceutical sciences, 39, 402-411. doi:10.1016/j.ejps.2010.01.010
  4. 86. Lamoral-Theys, D., Le Mercier, M., Le Calve, B., Rynkowski, M., Bruyère, C., Decaestecker, C., Haibe-Kains, B., Bontempi, G., Dubois, J., Lefranc, F., & Kiss, R. (2010). Long-term temozolomide treatment induces marked amino metabolism modifications and an increase in TMZ sensitivity in Hs683 oligodendroglioma cells. Neoplasia (New York, N.Y.), 12(1), 69-79. doi:10.1593/neo.91360
  5. 87. Adanja, I., Debeir, O., Megalizzi, V., Kiss, R., Warzée, N., & Decaestecker, C. (2010). Automated tracking of unmarked cells migrating in three-dimensional matrices applied to anti-cancer drug screening. Experimental cell research, 316(2), 181-193. doi:10.1016/j.yexcr.2009.10.004
  6. 88. Lamoral-Theys, D., Decaestecker, C., Mathieu, V., Dubois, J., Kornienko, A., Kiss, R., Evidente, A., & Pottier, L. (2010). Lycorine and its derivatives for anticancer drug design. Mini-reviews in medical chemistry, 10(1), 41-50. doi:10.2174/138955710791112604
  7. 89. Cludts, S., Decaestecker, C., Mahillon, V., Chevalier, D., Kaltner, H., André, S., Remmelink, M., Leroy, X., Gabius, H.-J., & Saussez, S. (2009). Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectin-1, -3 and -7. Anticancer research, 29(12), 4933-4940.
  8. 90. Megalizzi, V., Decaestecker, C., Debeir, O., Spiegl-Kreinecker, S., Berger, W., Lefranc, F., Kast, R. E., & Kiss, R. (2009). Screening of anti-glioma effects induced by sigma-1 receptor ligands: potential new use for old anti-psychiatric medicines. European journal of cancer, 45(16), 2893-2905. doi:10.1016/j.ejca.2009.07.011
  9. 91. Leyman, S., Sidani, M., Ritsma, L., Waterschoot, D., Eddy, R., Dewitte, D., Debeir, O., Decaestecker, C., Vandekerckhove, J., van Rheenen, J., Ampe, C., Condeelis, J., & Van Troys, M. (2009). Unbalancing the phosphatidylinositol-4,5-bisphosphate-cofilin interaction impairs cell steering. Molecular biology of the cell, 20(21), 4509-4523. doi:10.1091/mbc.E09-02-0121
  10. 92. Decaestecker, C., Moles Lopez, X., D'Haene, N., Roland, I., Guendouz, S., Duponchelle, C., Berton, A., Debeir, O., & Salmon, I. (2009). Requirements for the valid quantification of immunostains on tissue microarray materials using image analysis. Proteomics, 9(19), 4478-4494. doi:10.1002/pmic.200800936
  11. 93. Mathieu, A., Weynand, B., Verbeken, E., Da Silva, S., Decaestecker, C., Salmon, I., & Demetter, P. (2009). Comparison of four antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in non-small cell lung cancer. Lung cancer, 1301, 152-162. doi:10.1016/j.lungcan.2009.09.003
  12. 94. Lefranc, F., Sauvage, S., Van Goietsenoven, G., Megalizzi, V., Lamoral-Theys, D., Debeir, O., Spiegl-Kreinecker, S., Berger, W., Mathieu, V., Decaestecker, C., & Kiss, R. (2009). Narciclasine, a plant growth modulator, activates Rho and stress fibers in glioblastoma cells. Molecular cancer therapeutics, 8(7), 1739-1750. doi:10.1158/1535-7163.MCT-08-0932
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 Suivant >>